MAP-2A Activators
Microtubule-associated protein 2A (MAP-2A) is a pivotal cellular component that plays a crucial role in stabilizing microtubules within neuronal cells. As a member of the MAP2 family, MAP-2A is instrumental in maintaining the structural integrity of neurons and is essential for proper synaptic function and plasticity. Microtubules, which are the scaffolds of the cytoskeleton, provide support for the cellular architecture and are highways for intracellular transport. MAP-2A binds to these microtubules, enhancing their stability and promoting their assembly, which is vital for nerve cell development and dendritic branching. The expression of MAP-2A is not uniform; it varies according to the cell type and developmental stage, indicating its expression is tightly regulated by a complex network of signaling pathways that respond to various extracellular and intracellular stimuli.
A variety of chemical compounds have been identified that can potentially upregulate the expression of MAP-2A, working through different molecular mechanisms to stimulate cellular pathways that influence gene expression. Forskolin, for instance, can catalyze the conversion of ATP to cAMP, a second messenger that activates protein kinase A (PKA) and can lead to the upregulation of genes responsible for neuronal growth and plasticity, including MAP-2A. Epigallocatechin gallate (EGCG), a polyphenol found in green tea, may exert its effects by activating pathways that lead to the enhanced survival and health of neurons, possibly stimulating the expression of MAP-2A in the process. Additionally, lithium, commonly known for its mood-stabilizing properties, indirectly inhibits glycogen synthase kinase-3 (GSK-3), an enzyme that negatively regulates numerous transcription factors. By inhibiting GSK-3, lithium may facilitate the activation of transcriptional programs that include MAP-2A expression. Furthermore, valproic acid, a compound with a broad spectrum of action, is known to inhibit histone deacetylases (HDACs). This inhibition can result in a more open chromatin structure, allowing transcription factors greater access to genes, potentially leading to increased transcription of MAP-2A. Lastly, trichostatin A (TSA), another HDAC inhibitor, can create a transcriptionally permissive environment, which might similarly stimulate MAP-2A gene expression. These compounds, through their diverse actions on cellular pathways, underscore the complexity of regulating protein expression within the cell, highlighting the intricate web of control that governs cellular function and homeostasis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can elevate intracellular cAMP levels, which in turn may stimulate MAP2 expression by activating PKA, leading to phosphorylation of transcription factors that drive neuronal gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts as a ligand for retinoic acid receptors that can bind to retinoic acid response elements in DNA, potentially upregulating MAP2 expression during neurogenesis. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate could upregulate MAP2 expression by activating signaling pathways that promote neuronal survival, possibly via its role in modulating the activity of kinases and phosphatases. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can inhibit GSK-3β, which may lead to the stabilization and increased activity of beta-catenin, a transcriptional coactivator that could upregulate genes including those coding for MAP2. | ||||||
Kinetin | 525-79-1 | sc-207780 sc-207780A | 1 g 5 g | $38.00 $48.00 | ||
Kinetin might stimulate MAP2 expression through its role in cellular signaling, potentially by enhancing nucleic acid synthesis and modifying the expression of genes involved in cell growth. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could upregulate MAP2 expression by activating transcription factors like NF-κB, which are involved in the expression of genes related to neuronal development and plasticity. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea can increase the expression of genes involved in the response to cellular stress, potentially leading to the upregulation of MAP2 as part of a protective response in neurons. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium nitroferricyanide(III) dihydrate releases nitric oxide, which can stimulate MAP2 expression by activating guanylate cyclase and increasing cGMP, a second messenger in neuroprotective pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which may stimulate MAP2 expression by phosphorylating transcription factors or proteins that control gene expression related to neuronal structure. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram elevates cAMP by inhibiting its breakdown, which can lead to the activation of CREB, a transcription factor that may increase MAP2 transcription in neuronal cells. | ||||||